Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalyst Biosciences, Centocor R&D Enter Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Catalyst Biosciences, Centocor R&D Enter Discovery Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalyst Biosciences, Inc. has entered into an exclusive worldwide research and license agreement with Centocor R&D, Inc. Centocor will support Catalyst’s discovery research and preclinical development of Alterase drug candidates against two targets. The first target is in inflammatory disease, with an option to expand the agreement to include a third target. Alterase therapeutics are next-generation protease biologics engineered to catalytically split and inactivate disease-causing proteins.
   
Catalyst Biosciences will receive an upfront payment of $11 million, which includes cash, research funding for two years, and an equity investment by Johnson & Johnson Development Corp. (JJDC). Centocor will be responsible for all development, manufacturing, and commercialization associated with the Alterase products resulting from the collaboration in exchange for future milestones and royalties.  
   
“We are very pleased to collaborate with Centocor, a leading developer of biologic therapies, to employ our Alterase drug discovery engine against high-value targets,” said Nassim Usman, Ph.D., chief executive officer of Catalyst Biosciences. “We are also delighted to welcome JJDC to our premier group of investors.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics